These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27157889)

  • 1. Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.
    Schaake W; van der Schaaf A; van Dijk LV; Bongaerts AH; van den Bergh AC; Langendijk JA
    Radiother Oncol; 2016 Jun; 119(3):381-7. PubMed ID: 27157889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the RADAR prostate radiation therapy trial.
    Ebert MA; Foo K; Haworth A; Gulliford SL; Kennedy A; Joseph DJ; Denham JW
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):595-603. PubMed ID: 25596108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric analysis of patients receiving radiotherapy with VMAT technique in localized prostate cancer and its correlation with side effects.
    Akay SU; Çetin İA; Bekiroğlu GN
    J Cancer Res Ther; 2023; 19(3):801-807. PubMed ID: 37470614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT).
    Yang Y; Vargas CE; Bhangoo RS; Wong WW; Schild SE; Daniels TB; Keole SR; Rwigema JM; Glass JL; Shen J; DeWees TA; Liu T; Bues M; Fatyga M; Liu W
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1189-1199. PubMed ID: 33621660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensity-modulated radiotherapy for prostate cancer.
    Bae BK; Kim JE; Pyo H; Hong SN; Park W
    Sci Rep; 2023 Dec; 13(1):22099. PubMed ID: 38092835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of machine learning methods for prediction of acute and late rectal toxicity due to curative prostate radiotherapy.
    Ozkan EE; Serel TA; Soyupek AS; Kaymak ZA
    Radiat Prot Dosimetry; 2024 Aug; 200(13):1244-1250. PubMed ID: 38932433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal contractility in patients with fecal incontinence and obstructed defecation compared to normal subjects.
    Gregersen H; Mittal RK
    Gastro Hep Adv; 2023; 2(5):656-659. PubMed ID: 37464998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood in stool: The main cause is obstipation].
    Wintermeyer P
    MMW Fortschr Med; 2023 Oct; 165(Suppl 3):80-81. PubMed ID: 37857973
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment Optimization in Linac-Based SBRT for Localized Prostate Cancer: A Single-Arc versus Dual-Arc Plan Comparison.
    Panizza D; Faccenda V; Arcangeli S; De Ponti E
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics based predictive modeling of rectal toxicity in prostate cancer patients undergoing radiotherapy: CT and MRI comparison.
    Hassaninejad H; Abdollahi H; Abedi I; Amouheidari A; Tavakoli MB
    Phys Eng Sci Med; 2023 Dec; 46(4):1353-1363. PubMed ID: 37556091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation.
    Chilukuri S; Sundar S; Patro K; Sawant M; Sivaraman R; Arjunan M; Panda PK; Sharma D; Jalali R
    Int J Part Ther; 2022; 9(1):42-53. PubMed ID: 35774485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study.
    Yang X; Zhou B; Zhou L; Cui L; Zeng J; Wang S; Shi W; Zhang Y; Luo X; Xu C; Xue Y; Chen H; Chen S; Wang G; Guo L; Jose PA; Wilcox CS; Wu S; Wu G; Zeng C
    Front Cardiovasc Med; 2022; 9():794768. PubMed ID: 35360013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two independent dose prediction methods to personalize the automated radiotherapy planning process for prostate cancer.
    Kusters M; Miki K; Bouwmans L; Bzdusek K; van Kollenburg P; Smeenk RJ; Monshouwer R; Nagata Y
    Phys Imaging Radiat Oncol; 2022 Jan; 21():24-29. PubMed ID: 35146138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer.
    Pedersen J; Liang X; Bryant C; Mendenhall N; Li Z; Muren LP
    Phys Imaging Radiat Oncol; 2021 Oct; 20():62-68. PubMed ID: 34805558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients.
    Puttanawarut C; Sirirutbunkajorn N; Khachonkham S; Pattaranutaporn P; Wongsawat Y
    Radiat Oncol; 2021 Nov; 16(1):220. PubMed ID: 34775975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
    Park J; Park J; Oh S; Yea JW; Lee JE; Park JW
    PLoS One; 2021; 16(9):e0257216. PubMed ID: 34506581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review.
    Sargos P; Faye MD; Bacci M; Supiot S; Latorzeff I; Azria D; Niazi TM; Vuong T; Vendrely V; de Crevoisier R
    Front Oncol; 2021; 11():666962. PubMed ID: 34221983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder.
    Zhou J; Zhou J; Sun Z; Feng L; Zhu X; Yang J; Wang G
    Front Psychiatry; 2021; 12():593710. PubMed ID: 34093252
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
    Brand DH; Brüningk SC; Wilkins A; Fernandez K; Naismith O; Gao A; Syndikus I; Dearnaley DP; Tree AC; van As N; Hall E; Gulliford S;
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):596-608. PubMed ID: 33412260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial.
    Heemsbergen WD; Incrocci L; Pos FJ; Heijmen BJM; Witte MG
    Front Oncol; 2020; 10():469. PubMed ID: 32346534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.